Inhibition of emesis during disease processes such as parvoviral gastr
oenteritis can avert serious electrolyte imbalances following persiste
nt vomition, The goal of this study was to investigate the use of proc
hlorperazine in the cessation of emesis in canine patients. A fetal of
17 cases are described which employed dosing at 0.367 mg/kg (diluted
intravenously) to determine the antiemetic effectiveness of prochlorpe
razine in dogs. Fifteen cases of which emesis was a principle clinical
sign among the varied diagnoses were treated successfully with prochl
orperazine. Prochlorperazine appears to be an effective antiemetic for
use in treating canine emesis of various etiologies.